vs
Cytek Biosciences, Inc.（CTKB）とSilvercrest Asset Management Group Inc.（SAMG）の財務データ比較。上の社名をクリックして会社を切り替えられます
Cytek Biosciences, Inc.の直近四半期売上が大きい（$62.1M vs $32.0M、Silvercrest Asset Management Group Inc.の約1.9倍）。Silvercrest Asset Management Group Inc.の純利益率が高く（-0.4% vs -70.9%、差は70.6%）。Cytek Biosciences, Inc.の前年同期比売上増加率が高い（8.1% vs -0.0%）。Silvercrest Asset Management Group Inc.の直近四半期フリーキャッシュフローが多い（$15.0M vs $-1.8M）。過去8四半期でCytek Biosciences, Inc.の売上複合成長率が高い（17.7% vs 2.7%）
Cytek Biosciences社は高性能フローサイトメトリーシステム、関連試薬、解析ソフトウェアの開発・製造・販売を事業とし、ライフサイエンス研究、臨床診断、バイオ医薬品開発分野の顧客向けにサービスを提供し、北米、欧州、アジア太平洋などの地域に顧客基盤を持つ。
CTKB vs SAMG — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $62.1M | $32.0M |
| 純利益 | $-44.1M | $-120.0K |
| 粗利率 | 52.9% | — |
| 営業利益率 | -9.0% | -2.8% |
| 純利益率 | -70.9% | -0.4% |
| 売上前年比 | 8.1% | -0.0% |
| 純利益前年比 | -557.1% | -107.4% |
| EPS（希薄化後） | — | $0.02 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $62.1M | $32.0M | ||
| Q3 25 | $52.3M | $31.3M | ||
| Q2 25 | $45.6M | $30.7M | ||
| Q1 25 | $41.5M | $31.4M | ||
| Q4 24 | $57.5M | $32.0M | ||
| Q3 24 | $51.5M | $30.4M | ||
| Q2 24 | $46.6M | $31.0M | ||
| Q1 24 | $44.9M | $30.3M |
| Q4 25 | $-44.1M | $-120.0K | ||
| Q3 25 | $-5.5M | $618.0K | ||
| Q2 25 | $-5.6M | $1.9M | ||
| Q1 25 | $-11.4M | $2.5M | ||
| Q4 24 | $9.6M | $1.6M | ||
| Q3 24 | $941.0K | $2.3M | ||
| Q2 24 | $-10.4M | $2.7M | ||
| Q1 24 | $-6.2M | $3.0M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -2.8% | ||
| Q3 25 | -17.6% | 4.3% | ||
| Q2 25 | -23.3% | 13.2% | ||
| Q1 25 | -36.1% | 15.4% | ||
| Q4 24 | 5.2% | 6.1% | ||
| Q3 24 | -8.2% | 14.6% | ||
| Q2 24 | -18.3% | 17.1% | ||
| Q1 24 | -23.9% | 19.5% |
| Q4 25 | -70.9% | -0.4% | ||
| Q3 25 | -10.5% | 2.0% | ||
| Q2 25 | -12.2% | 6.3% | ||
| Q1 25 | -27.5% | 7.9% | ||
| Q4 24 | 16.8% | 5.1% | ||
| Q3 24 | 1.8% | 7.4% | ||
| Q2 24 | -22.4% | 8.6% | ||
| Q1 24 | -13.8% | 9.9% |
| Q4 25 | — | $0.02 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | — | $0.21 | ||
| Q1 25 | — | $0.26 | ||
| Q4 24 | — | $0.16 | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | — | $0.28 | ||
| Q1 24 | — | $0.32 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $90.9M | $44.1M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $341.7M | $50.3M |
| 総資産 | $461.5M | $166.6M |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $90.9M | $44.1M | ||
| Q3 25 | $93.3M | $36.1M | ||
| Q2 25 | $75.5M | $30.0M | ||
| Q1 25 | $95.3M | $36.3M | ||
| Q4 24 | $98.7M | $68.6M | ||
| Q3 24 | $162.3M | $58.1M | ||
| Q2 24 | $177.9M | $49.9M | ||
| Q1 24 | $168.8M | $39.7M |
| Q4 25 | $341.7M | $50.3M | ||
| Q3 25 | $378.6M | $58.9M | ||
| Q2 25 | $377.6M | $64.6M | ||
| Q1 25 | $379.6M | $80.0M | ||
| Q4 24 | $395.7M | $80.7M | ||
| Q3 24 | $385.5M | $84.6M | ||
| Q2 24 | $389.1M | $85.3M | ||
| Q1 24 | $392.6M | $83.9M |
| Q4 25 | $461.5M | $166.6M | ||
| Q3 25 | $494.9M | $157.6M | ||
| Q2 25 | $493.3M | $152.7M | ||
| Q1 25 | $482.6M | $159.9M | ||
| Q4 24 | $499.5M | $194.4M | ||
| Q3 24 | $491.2M | $184.2M | ||
| Q2 24 | $483.7M | $177.6M | ||
| Q1 24 | $492.1M | $170.2M |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-771.0K | $18.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $-1.8M | $15.0M |
| FCFマージンFCF / 売上 | -2.9% | 46.9% |
| 設備投資強度設備投資 / 売上 | 1.6% | 11.4% |
| キャッシュ転換率営業CF / 純利益 | — | — |
| 直近12ヶ月FCF直近4四半期 | $-8.8M | $17.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-771.0K | $18.6M | ||
| Q3 25 | $-3.9M | $14.6M | ||
| Q2 25 | $108.0K | $13.8M | ||
| Q1 25 | $-125.0K | $-24.7M | ||
| Q4 24 | $2.0M | $21.6M | ||
| Q3 24 | $13.2M | $13.3M | ||
| Q2 24 | $6.2M | $16.0M | ||
| Q1 24 | $4.0M | $-24.1M |
| Q4 25 | $-1.8M | $15.0M | ||
| Q3 25 | $-4.6M | $13.8M | ||
| Q2 25 | $-1.5M | $13.4M | ||
| Q1 25 | $-974.0K | $-25.1M | ||
| Q4 24 | $1.1M | $19.9M | ||
| Q3 24 | $12.2M | $12.9M | ||
| Q2 24 | $5.2M | $15.6M | ||
| Q1 24 | $3.4M | $-24.7M |
| Q4 25 | -2.9% | 46.9% | ||
| Q3 25 | -8.7% | 44.1% | ||
| Q2 25 | -3.2% | 43.6% | ||
| Q1 25 | -2.3% | -80.0% | ||
| Q4 24 | 1.9% | 62.2% | ||
| Q3 24 | 23.7% | 42.4% | ||
| Q2 24 | 11.0% | 50.4% | ||
| Q1 24 | 7.6% | -81.6% |
| Q4 25 | 1.6% | 11.4% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 3.5% | 1.5% | ||
| Q1 25 | 2.0% | 1.3% | ||
| Q4 24 | 1.6% | 5.3% | ||
| Q3 24 | 2.0% | 1.2% | ||
| Q2 24 | 2.3% | 1.1% | ||
| Q1 24 | 1.3% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.62× | ||
| Q2 25 | — | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | 0.21× | 13.34× | ||
| Q3 24 | 14.05× | 5.90× | ||
| Q2 24 | — | 6.00× | ||
| Q1 24 | — | -8.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
